Extension Study up to 3 Years for Secukinumab in Psoriatic Arthritis
Clinical trial NCT01892436 · COMPLETED
Trial details
- NCT number
- NCT01892436
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-30
- Primary completion
- 2018-01-11
- Enrollment
- 460
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.